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Abstract
Background: A growing body of evidence suggests that metabolic syndrome is associated with endocrine
disorders including thyroid dysfunction. Thyroid dysfunction in metabolic syndrome patients may further add to
cardiovascular disease risk thereby increasing mortality. This study was done to assess thyroid function in metabolic
syndrome patients and evaluate its relationship with the components of metabolic syndrome.
Methods: A cross sectional study was carried out among 169 metabolic syndrome patients at B P Koirala Institute
of Health Sciences, Dharan, Nepal. Anthropometric measurements (height, weight, waist circumference) and blood
pressure were taken. Fasting blood samples were analysed to measure glucose, triglyceride, high density lipoprotein
(HDL) cholesterol and thyroid hormones (triiodothyronine, thyroxine and thyroid stimulating hormone).
Results: Thyroid dysfunction was seen in 31.9 % (n = 54) metabolic syndrome patients. Subclinical hypothyroidism
(26.6 %) was the major thyroid dysfunction followed by overt hypothyroidism (3.5 %) and subclinical hyperthyroidism
(1.7 %). Thyroid dysfunction was much common in females (39.7 %, n = 29) than males (26 %, n = 25) but not statistically
significant (p = 0.068). The relative risk of having thyroid dysfunction in females was 1.525 (CI: 0.983–2.368) as compared to
males. Significant differences (p = 0.001) were observed in waist circumference between patients with and without
thyroid dysfunction and HDL cholesterol which had significant negative correlation with thyroid stimulating hormone.
Conclusions: Thyroid dysfunction, particularly subclinical hypothyroidism is common among metabolic syndrome
patients, and is associated with some components of metabolic syndrome (waist circumference and HDL cholesterol).
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Background
Metabolic syndrome constitutes a cluster of risk factors
characterized by hypertension, atherogenic dyslipidemia,
hyperglycemia, prothrombotic and proinflammatory condi-
tions [1]. This cluster of metabolic abnormalities is associ-
ated with increased risk for atherosclerotic cardiovascular
disease and type 2 diabetes mellitus [2]. The prevalence of
metabolic syndrome is increasing all over the world with
distinct evidence of high prevalence in India and other
South Asian countries [3].
Thyroid dysfunction, prominently subclinical hypo-
thyroidism has been observed more frequently in meta-
bolic syndrome patients than general population [3].
Both metabolic syndrome and hypothyroidism are inde-
pendent risk factors for cardiovascular diseases (CVD).
Presence of both conditions may be compounded to
increase the risk for CVD and a considerable overlap
occurs in the pathogenic mechanisms of atherosclerotic
cardiovascular disease by metabolic syndrome and
hypothyroidism [4]. There are reports about higher
thyroid stimulating hormone (TSH) level in metabolic
syndrome patients than in healthy ones, and high preva-
lence of metabolic syndrome in subjects with TSH level
higher than normal as compared to those with normal
TSH level [5, 6]. However the association between
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thyroid dysfunction and components of metabolic syn-
drome is still debatable [7].
There is evidence that thyroid function may need to
be assessed in patients with metabolic syndrome who
are also at higher risk for CVD. Thyroid dysfunction is
common in Nepal, and the prevalence of diabetes melli-
tus and metabolic syndrome has been rising steadily.
Reports suggest that 20.7 % of the Nepalese population
have metabolic syndrome based on National Cholesterol
Education Program (NCEP) criteria [8, 9]. However,
thyroid function in such patients is not well studied. A
study by Gyawali et al. in the central region of Nepal
reported thyroid dysfunction in 31.8 % of metabolic syn-
drome patients [3]. We conducted the present study
among metabolic syndrome patients in the eastern re-
gion of Nepal to assess the rate of thyroid dysfunction
and explore the potential relationship between compo-
nents of metabolic syndrome and thyroid function, and
provide evidence for the better clinical management of
metabolic syndrome patients. The present study aims to
evaluate the pattern of thyroid dysfunction in Nepalese
metabolic syndrome patients.
In this study, we assessed thyroid function and exam-
ined the association between components of metabolic
syndrome and thyroid function in Nepalese population
with metabolic syndrome.
Methods
A cross-sectional study was conducted among metabolic
syndrome patients at the department of biochemistry of B
P Koirala Institute of Health Sciences (BPKIHS), Dharan,
Nepal from September 2013 to September 2014. One
hundred sixty nine metabolic syndrome patients aged
≥20 years were selected from the hospital during the study
period. The sample size was calculated by taking preva-
lence of thyroid dysfunction as 15 % (approximate) in this
region. Metabolic syndrome was diagnosed based on
modified Asian NCEP-ATP III panel criteria [10]. The
exclusion criteria was patients receiving medication that
may alter thyroid functions or lipid levels, pregnant
women, and patients with a cardiovascular disease, cor-
ticosteroid use, active liver disease, and renal dysfunction.
After taking informed consent from each patient, height,
weight, waist circumference and blood pressure was taken
from each subject. The study protocol was approved by
the institute review board of B P Koirala Institute of
Health Sciences. Fasting venous blood samples (5 ml)
were collected and analyzed for blood glucose, triglycer-
ides, high density lipoprotein (HDL) cholesterol, free tri-
iodothyronine (T3), free thyroxine (T4) and thyroid
stimulating hormone (TSH). Blood glucose and triglycer-
ides were measured by enzymatic method (kits from
AGAPPE diagnostics by Biolyzer 100) and HDL choles-
terol by homogeneous, direct method (kits from Gesan by
Biolyzer 100). Serum free T3, free T4 and TSH were
measured by using fluorescent immunoassay (VIDAS, bio-
meriux SA, France).
Metabolic syndrome patients were considered to have
thyroid dysfunction if patients thyroid hormones level
fell outside the reference range (free T3 (4.0–8.3 pmol/
L), free T4 (9.0–20.0 pmol/L) and TSH level (0.25–5
mIU/L)). Patients were said to be euthyroid if all thyroid
hormone levels fell within reference range. Overt
hypothyroidism was defined as TSH > 5 mIU/L and free
T3 < 4.0 pmol/L and free T4 < 9.0 pmol/L. Subclinical
hypothyroidism was considered if TSH > 5 mIU/L and
free T3 and free T4 within reference range. Subclinical
hyperthyroidism was defined as TSH < 0.25 mIU/L and
free T3 and free T4 within reference range. The data
generated from study was analyzed using SPSS version
11.0. Continuous variables were expressed as mean ± SD
values. Independent sample t test and one way ANOVA
was applied for continuous variables and chi square test
for categorical variables at 95 % confidence interval.
Pearson correlation coefficients were calculated to find
relationship between the components of metabolic syn-
drome and thyroid profile parameters at 95 % confi-
dence interval. Relative risk with 95 % confidence
interval (CI) was used to assess the risk factors for thy-
roid dysfunction in metabolic syndrome.
Results
The study population consisted of 56.8 % (n = 96) males
and 43.2 % (n = 73) females, with mean age of 47 ±
12.5 years. Height, weight, body mass index (BMI), waist
circumference, systolic BP and diastolic BP were 157.4 ±
8 cm, 70.7 ± 7.9 Kg, 28.6 ± 3.3 Kg/m2, 102.5 ± 6.7 cm,
129.3 ± 13.6 mmHg and 84.9 ± 11.5 mmHg respectively.
Similarly, levels of biochemical parameters; fasting blood
glucose, triglyceride, HDL cholesterol, free T3, free T4
and TSH were 126.2 ± 50.4 mg/dL, 198.2 ± 90.8 mg/dL,
49.9 ± 15.3 mg/dL, 5.1 ± 1.0 pmol/L, 12.0 ± 2.9 pmol/L
and 4.2 ± 3.4 mIU/L respectively. Thyroid dysfunction
was found in 31.9 % (n = 54) patients. Subclinical
hypothyroidism (26.6 %) was the major thyroid dysfunc-
tion followed by overt hypothyroidism (3.5 %) and sub-
clinical hyperthyroidism (1.7 %). Components of
metabolic syndrome according to thyroid dysfunction
type are shown in Table 1. Waist circumference and
blood glucose was significantly different across the thy-
roid dysfunction groups. Thyroid dysfunction was more
common among females 39.7 % (n = 29) than males
26 % (n = 25) but not statistically significant (p = 0.068).
Among males, 23 had subclinical hypothyroidism, 1 had
overt hypothyroidism and 1 had subclinical hyperthy-
roidism. Similarly among females, 22 had subclinical
hypothyroidism, 5 had overt hypothyroidism and 2 had
subclinical hyperthyroidism. The relative risk of having
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thyroid dysfunction in females was 1.525 (0.983–2.368;
p = 0.068) as compared to males. When metabolic syn-
drome parameters were compared between the patients
subgroups (with TSH < 5 mIU/L and TSH ≥ 5 mIU/L),
then systolic BP, diastolic BP, waist circumference, blood
glucose, triglyceride and HDL cholesterol were 129.7 ±
12.6 mmHg versus 128.4 ± 16 mmHg; p = 0.602, 85.3 ±
11 mmHg versus 84 ± 12.8 mmHg; p = 0.513, 103.4 ±
6.6 cm versus 100.5 ± 6.6 cm; p = 0.008, 125.2 ± 53.2 mg/
dL versus 128.6 ± 43.7 mg/dL; p = 0.692, 189.7 ±
75.5 mg/dL versus 217.9 ± 117.6 mg/dL; p = 0.119 and
51 ± 16.8 mg/dL versus 47.4 ± 11 mg/dL; p = 0.103
respectively. Correlation between the components of
metabolic syndrome and TSH and free T4 is shown in
Table 2. HDL cholesterol showed significant negative
correlation with TSH level. BMI had negative correl-
ation with free T3 (r = -0.161, p = 0.037) and free T4
(r = -0.15, p = 0.052) and weak positive correlation
with TSH (r = 0.105, p = 0.174).
Discussion
Metabolic syndrome can be associated with endocrine
and non-endocrine disorders and has widespread conse-
quences. Alterations in thyroid functions, though well
known, are not recognized clinically and there is incon-
sistency in thyroid functions in metabolic syndrome
[11]. The present study identifies thyroid dysfunction as
a common endocrine disorder in metabolic syndrome
patients; subclinical hypothyroidism (26.6 %) was the
commonest followed by overt hypothyroidism (3.5 %)
and subclinical hyperthyroidism (1.7 %). Our findings
are consistent with previous studies investigating thyroid
function in metabolic syndrome patients. A study by Gya-
wali et al. in Kavre district of central Nepal reported thyroid
dysfunction in 31.84 % of metabolic syndrome patients, the
most common dysfunction was subclinical hypothyroidism
(29.32 %) followed by overt hypothyroidism (1.67 %) and
subclinical hyperthyroidism (0.83 %) [3]. Previous studies in
eastern Nepal have also reported higher rate of thyroid
dysfunction. Though, thyroid function status of adult popu-
lation from cross-sectional studies in community settings
are unavailable, hospital based studies by Baral et al. and
Khatiwada et al. have reported higher rate of thyroid disor-
ders [8, 12]. Study by Baral et al. in eastern Nepal reported
hyperthyroid and hypothyroid in 13.68 % and 17.19 % of
the general population respectively. Similarly, Khatiwada
et al. observed thyroid dysfunction in 36 % of diabetes mel-
litus patients in a tertiary hospital of eastern Nepal. Preva-
lence of higher rates of thyroid dysfunction in this region
may be due to higher rate of thyroid autoimmunity, iodine
deficiency or iodine excess [12]. Recent findings about
iodine nutrition among children of this region indicate
excess iodine intake in these areas as revealed by excess
urinary iodine excretion [13]. A study in India by Shantha
et al. found subclinical hypothyroidism in 21.9 % and overt
hypothyroidism in 7.4 % metabolic syndrome patients [1].
Similarly, a study by Meher et al. showed a high preva-
lence of subclinical hypothyroidism (22 %) and overt
hypothyroidism (4 %) in the metabolic syndrome patients
[14]. We observed thyroid dysfunction to be more com-
mon in females (39.7 %) than males (26 %) patients, and
this has been observed in a number of studies including
the general population [1].
The TSH level of metabolic syndrome patients in our
study was in upper normal range, which suggests some
degree of thyroid dysfunction in such patients. In a case
control study assessing CVD risk factors in an eastern
Nepalese population, the mean TSH level of a healthy
control population was 2.35 ± 1.07 mIU/L, which is lower
than the mean TSH of this present study [15]. The TSH
level was above the reference range for normal population
in the study of Gyawali et al., and they also observed
significantly higher TSH level in metabolic syndrome
patients as compared to controls [3]. A positive associ-
ation has also been reported, between a higher TSH level
Table 1 Components of metabolic syndrome among different thyroid dysfunction group
Parameters Euthyroid N = 115 Overt hypothyroid N = 6 Subclinical hypothyroid N = 45 Subclinical hyperthyroid N = 3
Systolic BP (mmHg) 129.7 ± 12.7 130 ± 10.9 128.2 ± 16.6 131.6 ± 2.8
Diastolic BP (mmHg) 85.5 ± 10.9 85.8 ± 15.3 83.7 ± 12.5 76.7 ± 15.2
Waist circumference (Cm) 103.7 ± 6.4 99.3 ± 8.5 100.6 ± 6.4 92.3 ± 4.6
Blood glucose (mg/dL) 123 ± 51 106.1 ± 32.2 131.5 ± 44.4 209.6 ± 75.1
Triglyceride (mg/dL) 190.5 ± 75.7 201.6 ± 69 220.1 ± 123 158 ± 75.7
HDL cholesterol (mg/dL) 51 ± 17 50 ± 12.4 47 ± 10.9 49.3 ± 1.1
Table 2 Correlation of components of metabolic syndrome
with TSH and free T4
Components TSH Free T4
R P value R P value
Systolic BP (mmHg) -0.001 0.985 0.062 0.421
Diastolic BP (mmHg) 0.077 0.321 -0.141 0.068
Waist circumference (Cm) -0.121 0.117 -0.056 0.469
Blood glucose (mg/dL) 0.059 0.444 -0.051 0.513
Triglyceride (mg/dL) 0.064 0.408 -0.035 0.65
HDL cholesterol (mg/dL) -0.174 0.024 0.1 0.195
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within the euthyroid reference range and the prevalence
of the metabolic syndrome [5]. A study in Korea indicated
that higher levels of TSH may predict the metabolic syn-
drome in the study subjects, suggesting that the influence
of thyroid function on metabolic abnormality extends into
subjects without metabolic syndrome [16]. In the present
study, subclinical hyperthyroid patients had highest sys-
tolic BP and fasting blood glucose, overt hypothyroid
patients had highest diastolic BP and euthyroid patients
had highest waist circumference. Highest triglyceride and
lowest HDL cholesterol was seen in patients with subclin-
ical hypothyroidism. It has been observed that subclinically
hypothyroid patients have higher systolic BP, diastolic BP,
fasting blood glucose and triglycerides compared to euthyr-
oid patients [17]. In our previous case control study, we
observed that subclinical hypothyroidism patients have
significantly higher diastolic BP, total cholesterol, LDL chol-
esterol and hs-CRP than euthyroid controls [15]. Our
current findings may be due to small number of thyroid
dysfunction patients (overt hypothyroidism and subclinical
hyperthyroidism). Hypothyroidism is associated with fac-
tors of metabolic syndrome such as dyslipidemia, hyperten-
sion, obesity, and often insulin resistance. It has been
reported that 95 % of newly diagnosed hypothyroid patients
have increased levels of cholesterol and 5 % of have
hypertriglyceridemia. Hypothyroidism also leads to in-
creased level of LDL cholesterol. All these factors directly
contribute to accelerated atherosclerosis [18].
The correlation between subclinical hypothyroidism and
metabolic syndrome and its components varies in differ-
ent studies and seems to be influenced by age, gender and
race of study participants [19]. In the present study, waist
circumference was significantly different (p = 0.001) be-
tween patients with and without thyroid dysfunction, and
HDL cholesterol had significant negative association with
TSH level, however, other components of metabolic
syndrome had no significant relationships with thyroid
dysfunction. Thyroid hormones affect lipid metabolism
and thus the components of metabolic syndrome, and
there is positive relation between TSH and LDL choles-
terol, whereas negative relation between TSH and HDL
cholesterol [15]. Our findings are similar to previous
study, where no significant relationship between compo-
nents of metabolic syndrome and thyroid dysfunction
were found except for waist circumference [3]. There are
contrasting reports about the association between various
metabolic syndrome parameters and thyroid function. In a
study in Nigeria, metabolic syndrome was significantly
associated with higher free T4 levels [2]. In a study in
India, subclinical hypothyroidism was significantly associ-
ated with metabolic syndrome and a linear association
was observed between TSH levels and total cholesterol,
triglycerides, LDL, and HDL cholesterol levels across the
metabolic syndrome group [14]. However, in a study in
Turkey, TSH was not related with any metabolic syn-
drome parameters [20].
In the present study, we observed negative association
of BMI with free T3 and free T4 and weak positive correl-
ation with TSH. In a study in Germany, euthyroid subjects
with TSH in the upper normal range (2.5–4.5 mU/L) were
more obese (BMI > 30 Kg/m2), had higher triglyceride
levels, and an increased likelihood of having metabolic
syndrome [21].
High prevalence of overt and subclinical hypothyroidism
in metabolic syndrome as seen in our study may have
harmful effect on cardiovascular health. Hypothyroidism
will lead to increased lipid levels and hypertension leading
to increased risk for CVD. The effects due to metabolic
syndrome and hypothyroidism may be compounded to
increase risk for CVD [1]. Thus, assessing thyroid function
in metabolic syndrome patients may help identify patients
at high risk for CVD. However, it is still unclear whether
patients with subclinical hypothyroidism should be treated,
and the distinct benefit of prescribing levothyroxine for car-
diovascular benefits in these patients is still debatable [15].
The present study has however several limitations. First the
sample size was small, which may have affected the correl-
ation between components of metabolic syndrome and
thyroid function. Second, the iodine nutrition status in the
patients was not assessed. It has been found that both iod-
ine deficiency and excess can lead to thyroid disorder
particularly subclinical hypothyroidism. Also, the presence
of thyroid autoimmunity in the study population may lead
to higher rate of thyroid dysfunction [12].
Conclusions
In conclusion, the study finds thyroid dysfunction specif-
ically subclinical hypothyroidism is a common endocrine
disorder in Nepalese patients with metabolic syndrome,
and thyroid function is associated with certain compo-
nents of metabolic syndrome (waist circumference and
HDL cholesterol).
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